1. 112 1 Designing Drugs to Avoid Toxicity 233445GRAHAM F. SMITH 5667Central Chemistry Team Lead, Merck Research Laboratories Boston,7833 Avenue Louis Pasteur, Boston, MA…
1.The current state of bioinformatics in a bigpharma companyEagle Genomics Symposium, April 5th 2011Matt Hall, Team Leader, Computational Biology, GSK2. Outline of talk…
1. March2010 Introducing GenScript 2. Presentation Overview 1 2 3 4 The Biology CRO About GenScript Service Overview Your Reliable Partner 3. About GenScript Founded in 2002>800…
1. March2010 Introducing GenScript 2. Presentation Overview 1 2 3 4 The Biology CRO About GenScript Service Overview Your Reliable Partner 3. About GenScript Founded…
BioVariance Research Services Off-target profile prediction for Drug Candidates Josef Scheiber, PhD www.biovariance.com BioVariance - Overview Two distinct offerings rooted…
Backtranslating Information to Early Drug Discovery The impact of large-scale genetic data on drug targets – From 1000 genomes to Drug Discovery Josef Scheiber, PhD www.biovariance.com…
NMR in Fragment-Based Drug Discovery NMR Studies in Fragment-Based Drug Discovery Katie Strong March 20, 2013 Advisor: Dr. Dennis Liotta, Ph.D. 1 1 Bolten, B.M.; DeGregorio,…
Final AgendaREGISTER BY MARCH 13 AND SAVE UP TO $400! WorldPharmaCongress.com Preclinical Models in Oncology Imaging in Oncology Targeting GPCRs Predicting Drug Toxicity…
Slide 1Ten Years After: Where is ISAP? William A. Craig, M.D. University of Wisconsin Madison, WI Slide 2 Birth of ISAP 1986-89Informal discussions June1989Organizational…